These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 6445041)

  • 1. A new immunodeficiency disorder in humans involving NK cells.
    Roder JC; Haliotis T; Klein M; Korec S; Jett JR; Ortaldo J; Heberman RB; Katz P; Fauci AS
    Nature; 1980 Apr; 284(5756):553-5. PubMed ID: 6445041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chédiak-Higashi gene in humans. II. The selectivity of the defect in natural-killer and antibody-dependent cell-mediated cytotoxicity function.
    Klein M; Roder J; Haliotis T; Korec S; Jett JR; Herberman RB; Katz P; Fauci AS
    J Exp Med; 1980 May; 151(5):1049-58. PubMed ID: 6966316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency of inducible suppressor cell activity in the Chediak-Higashi syndrome.
    Nair MP; Gray RH; Boxer LA; Schwartz SA
    Am J Hematol; 1987 Sep; 26(1):55-66. PubMed ID: 2443005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chédiak-Higashi gene in humans I. Impairment of natural-killer function.
    Haliotis T; Roder J; Klein M; Ortaldo J; Fauci AS; Herberman RB
    J Exp Med; 1980 May; 151(5):1039-48. PubMed ID: 6154765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a murine model (beige) for a natural killer cell immunodeficiency in the Chediak-Higashi syndrome of man.
    Roder JC
    Prog Clin Biol Res; 1982; 94():315-25. PubMed ID: 7122620
    [No Abstract]   [Full Text] [Related]  

  • 6. Further studies of natural killer cell function in Chediak-Higashi patients.
    Roder JC; Haliotis T; Laing L; Kozbor D; Rubin P; Pross H; Boxer LA; White JG; Fauci AS; Mostowski H; Matheson DS
    Immunology; 1982 Jul; 46(3):555-60. PubMed ID: 6212535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Chediak-Higashi gene in humans. III. Studies on the mechanisms of NK impairment.
    Roder JC; Todd RF; Rubin P; Haliotis T; Helfand SL; Werkmeister J; Pross HF; Boxer LA; Schlossman SF; Fauci AS
    Clin Exp Immunol; 1983 Feb; 51(2):359-68. PubMed ID: 6839545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal levels of natural cytotoxic cells against solid tumours in NK-deficient beige mice.
    Stutman O; Cuttito MJ
    Nature; 1981 Mar; 290(5803):254-7. PubMed ID: 7207617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nature of natural killer cell hyporesponsiveness in the Chediak-Higashi syndrome.
    Brahmi Z
    Hum Immunol; 1983 Jan; 6(1):45-52. PubMed ID: 6219972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NK cell effector functions in a Chédiak-Higashi patient undergoing cord blood transplantation: Effects of in vitro treatment with IL-2.
    Cifaldi L; Pinto RM; Rana I; Caniglia M; Angioni A; Petrocchi S; Cancrini C; Cursi L; Palumbo G; Zingoni A; Gismondi A; Rossi P; Santoni A; Cerboni C
    Immunol Lett; 2016 Dec; 180():46-53. PubMed ID: 27816481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The thiol proteinase inhibitors improve the abnormal rapid down-regulation of protein kinase C and the impaired natural killer cell activity in (Chediak-Higashi syndrome) beige mouse.
    Ito M; Sato A; Tanabe F; Ishida E; Takami Y; Shigeta S
    Biochem Biophys Res Commun; 1989 Apr; 160(2):433-40. PubMed ID: 2541700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer (HNK-1+) cells in Chediak-Higashi patients are present in normal numbers but are abnormal in function and morphology.
    Abo T; Roder JC; Abo W; Cooper MD; Balch CM
    J Clin Invest; 1982 Jul; 70(1):193-7. PubMed ID: 7085883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphological and functional analysis of beige (Chèdiak-Higashi syndrome) mouse mast cells with giant granules.
    Kiyoi T; Liu S; Sahid MNA; Shudou M; Ogasawara M; Mogi M; Maeyama K
    Int Immunopharmacol; 2019 Apr; 69():202-212. PubMed ID: 30738290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered lectin-mediated cytotoxicity in Chédiak-Higashi syndrome patients.
    Merino F; Rodríguez F; Biondo-Bracho M; Amesty C; Ramírez-Duque P
    Clin Immunol Immunopathol; 1984 Nov; 33(2):139-43. PubMed ID: 6333304
    [No Abstract]   [Full Text] [Related]  

  • 15. Deficiency of active natural killer cells in the Chediak-Higashi syndrome. Localization of the defect using a single cell cytotoxicity assay.
    Katz P; Zaytoun AM; Fauci AS
    J Clin Invest; 1982 Jun; 69(6):1231-8. PubMed ID: 6177715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chediak-Higashi syndrome in an adult female].
    Utsunomiya A; Saito T; Hanada S; Tin E; Oshige T; Hashimoto S; Hamaguchi Y; Ueno T
    Rinsho Ketsueki; 1988 Sep; 29(9):1422-6. PubMed ID: 3216514
    [No Abstract]   [Full Text] [Related]  

  • 17. Gamma-delta T cells in Chediak-Higashi syndrome.
    Holcombe RF; van de Griend R; Ang SL; Bolhuis RL; Seidman JG
    Acta Haematol; 1990; 83(4):193-7. PubMed ID: 2115716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killing in immunodeficient patients.
    Koren HS; Amos DB; Buckley RH
    J Immunol; 1978 Mar; 120(3):796-9. PubMed ID: 632589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The "lazy" NK cells of Chediak-Higashi syndrome.
    Targan SR; Oseas R
    J Immunol; 1983 Jun; 130(6):2671-4. PubMed ID: 6602174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of natural killer and killer cells in concordant xenograft rejection.
    Patselas T; Thomas F; Araneda D; Marchman W
    Transplant Proc; 1995 Feb; 27(1):262-3. PubMed ID: 7878995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.